Danaher Corporation $DHR Shares Newly Purchased by Associated Banc Corp

Key Points

• Associated Banc Corp purchased a new 48,249-share stake in Danaher during the third quarter, valued at about $10.69 million. Institutional investors collectively own 79.05% of the company’s shares.
• Danaher reported quarterly EPS of $2.11, beating the $1.92 consensus estimate, while revenue of $6.55 billion was slightly below expectations; revenue rose 8.3% year over year.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $242.91. Danaher also paid a quarterly dividend of $0.40 per share, equivalent to a 0.7% annualized yield.

Associated Banc Corp acquired a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 48,249 shares of the conglomerate's stock, valued at approximately $10,690,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new position in Danaher in the 2nd quarter valued at approximately $10,492,520,000. Wellington Management Group LLP increased its holdings in shares of Danaher by 10.4% in the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock worth $3,108,031,000 after purchasing an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC purchased a new position in shares of Danaher in the second quarter worth $1,456,317,000. Generation Investment Management LLP purchased a new position in shares of Danaher in the second quarter worth $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher during the second quarter valued at $993,846,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

NYSE DHR opened at $229.99 on Wednesday. The business's fifty day moving average price is $219.38 and its 200-day moving average price is $201.70. The stock has a market capitalization of $161.80 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher's revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.89 earnings per share. On average, equities analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher's dividend payout ratio (DPR) is presently 26.19%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent analyst reports. Morgan Stanley increased their price objective on Danaher from $220.00 to $240.00 and gave the company an "overweight" rating in a research report on Monday, October 12th. Guggenheim boosted their target price on Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. upped their target price on shares of Danaher from $250.00 to $270.00 and gave the company an "overweight" rating in a research note on Thursday, October 22nd. Robert W. Baird raised their price target on shares of Danaher from $246.00 to $254.00 and gave the company an "outperform" rating in a report on Thursday, October 22nd. Finally, TD Cowen lifted their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a "buy" rating in a research note on Thursday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $242.91.

Insider Transactions at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of the business's stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 10.80% of the company's stock.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.